Early use of probiotics is important therapy in infants with severe congenital anomaly

Pediatrics International

Volumn 52, Issue 3, 2010, Pages 362-367

  Kanamori, Yutaka ^a   Iwanaka, Tadashi ^a   Sugiyama, Masahiko ^a   Komura, Makoto ^a   Takahashi, Takuya ^b   Yuki, Norikatsu ^b   Morotomi, Masami ^b   Tanaka, Ryuichiro ^b  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^b YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

Author keywords

Congenital anomaly; Prebiotics; Probiotics

Indexed keywords

ANTIBIOTIC AGENT; PROBIOTIC AGENT;

ANAEROBE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM DETECTION; BIFIDOBACTERIUM BREVE; BLADDER EXSTROPHY; CHILD GROWTH; CLINICAL ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN TISSUE; ILEUM; INFANT; INFECTION PREVENTION; INTESTINE ABSORPTION; INTESTINE ATRESIA; INTESTINE FLORA; LACTOBACILLUS CASEI; LUNG HYPOPLASIA; MALE; MECONIUM PERITONITIS; MENINGOMYELOCELE; NEWBORN; OMPHALOCELE; PRIORITY JOURNAL; SHORT INTESTINE HYPOPLASIA; TREATMENT DURATION; URINARY TRACT INFECTION; URORECTAL SEPTUM MALFORMATION;

ABNORMALITIES, MULTIPLE; BIFIDOBACTERIUM; CHILD DEVELOPMENT; COHORT STUDIES; CONGENITAL ABNORMALITIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; INTESTINAL DISEASES; INTESTINES; JAPAN; LACTOBACILLUS CASEI; MALE; POSTOPERATIVE CARE; PROBIOTICS; SEVERITY OF ILLNESS INDEX; SYNBIOTICS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77953646067     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2009.02963.x     Document Type: Article

References (16)

1. Gibson R, Roberfroid MB. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J. Nutr. 1995 125 : 1401 1412.
2. Kanamori Y, Hashizume K, Sugiyama M et al. Combination therapy with Bifidobacterium breve, Lactobacillus casei, and galactooligosaccharides dramatically improved the intestinal function in a girl with short bowel syndrome: A novel synbiotics therapy for intestinal failure. Dig. Dis. Sci. 2001 46 : 2010 2016.
3. Kanamori Y, Hashizume K, Sugiyama M et al. A novel synbiotic therapy dramatically improved the intestinal function of a pediatric patient with laryngotracheo-esophageal cleft (LTEC) in the intensive care unit. Clin. Nutr. 2002 21 : 527 530.
4. Kanamori Y, Sugiyama M, Hashizume K et al. Experience of long-term synbiotic therapy in seven short bowel patients with refractory enterocolitis. J. Pediatr. Surg. 2004 39 : 1686 1692.
5. Kanamori Y, Sugiyama M, Komura M et al. Synbiotic therapy: An important supportive therapy for pediatric patients with severe respiratory distress. Int. J. Probiot. Prebiot. 2006 1 : 161 168.
6. Holdeman LV, Cato EP, Moore WEC. Anaerobe Laboratory Manual, 4th edn. Virginia Polytechnic Institute and State University
7. Kanazawa H, Nagino M, Kamiya S et al. Synbiotics reduce postoperative infectious complications: A randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch. Surg. 2005 390 : 104 113.
8. Kado Y, Yuki N, Kushiro A et al. Survival of a probiotic, Bifidobacterium breve strain Yakult, in the human gastrointestinal tract: Selective isolation from feces and identification using randomly amplified polymorphic DNA polymerase chain reaction technique. J. Intest. Microbiol. 2001 15 : 9 14.
9. Yuki N, Watanabe K, Mike A et al. Survival of a probiotic, Lactobacillus casei strain Shirota, in the gastrointestinal tract: Selective isolation from faeces and identification using monoclonal antibodies. Int. J. Food Microbiol. 1999 48 : 51 7.
10. Kanamori Y, Sugiyama M, Goishi K et al. Abnormal intestinal microbiota in pediatric surgical patients and the effects of a newly designed synbiotic therapy. Int. J. Probiot. Prebiot. 2006 1 : 149 160.
11. Kanamori Y, Iwanaka T, Nakahara S et al. Survival in a neonate with complete urorectal malformation sequence after fetal vesico-amniotic shunting for a prominently dilated cloaca. Fetal Diagn. Ther. 2008 24 : 458 461.
12. Backhed F, Ding H, Wang T et al. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl Acad. Sci. USA 2004 101 : 15 718 23.
13. Van der Waaij D, Berghuis-De Vries JM, Lekkerkerk-Van der W. Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. J. Hyg. 1971 69 : 405 411.
14. Madson K, Cornish A, Soper P et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001 121 : 580 591.
15. Macpherson AJ, Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004 303 : 1662 1665.
16. Deshpande G, Rao S, Patole S. Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials. Lancet 2007 369 : 1614 1620.